Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Status: Unknown status Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20061
20081
20121
20132
20171
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellus Health Inc. - a GSK company3
National Taiwan University Hospital2
Brasilia University Hospital1
Imperial College London1
KeifeRx, LLC1
McMaster University1
Navidea Biopharmaceuticals1
New York State Institute for Basic Research1
Samsung Medical Center1
Shanghai Mental Health Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease13
Dementia3
Cerebral Amyloid Angiopathy1
Cerebral Hemorrhage1
Down Syndrome1
Inflammation1
Intracranial Hemorrhages1
Sleep Initiation and Maintenance Disorders1
Sleep Wake Disorders1
Stroke1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.